News
IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling InitiativeLeading AI-Powered Immune Profiling Company IMU to Adopt Pluto Workstation for Large-Scale Immune Phenotyping ...
The German Poppe + Potthoff group (P+P) is expanding its global reach with the opening of a new joint venture plant in India.
The live webcasts can be accessed in the investors section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events. Access to the webcast replays will be available ...
Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's ...
Precision BioSciences, Inc.’s DTIL share price has dipped by 9.90%, which has investors questioning if this is right time to ...
The firm must deprioritize a mitochondrial disease program in order to fast-track PBGENE-DMD to a Phase I study.
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the ...
5d
Zacks Investment Research on MSNPrecision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue EstimatesPrecision BioSciences (DTIL) came out with a quarterly loss of $2.21 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.35 per share a year ago. These ...
DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — Precision BioSciences Inc. (DTIL) on Thursday reported a loss of $20.6 million in its first quarter. On a per-share basis, the Durham, North Carolina-based ...
Analysts estimate that Precision BioSciences will report an earnings per share (EPS) of $-2.42. Precision BioSciences bulls ...
Precision BioSciences (NASDAQ:DTIL) is scheduled to announce Q1 earnings results on Thursday, May 15th, before market open. The consensus EPS Estimate is -$2.42 (-242.4% Y/Y) and the consensus Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results